Supplier
New York City Health and Hospitals Corporation
New York City Health and Hospitals Corporation was paid $34.62M by Medicaid between Jan 2018 and Dec 2024, across 286 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 19% of everything it billed.
33Billing provider infoNEW YORK CITY HEALTH AND HOSPITALS CORPORATION
BRONX, NY 10452
BRONX, NY 10452
33aNPI1003824608assigned 08/03/2006
33bProvider typeInstitutional Pharmacy
28Total paid$34.62M
24GClaims949,429
24DCodes billed286
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KARLIN, MARJI controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30,627 | $860K | |
| 2019 | 71,837 | $2.44M | |
| 2020 | 161,862 | $6.39M | |
| 2021 | 254,949 | $9.03M | |
| 2022 | 165,353 | $6.15M | |
| 2023 | 133,400 | $4.95M | |
| 2024incomplete | 131,401 | $4.80M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 80,687 | 63,583 | $6.45M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6.7% | 33,717 | 26,079 | $2.31M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.6% | 29,357 | 24,830 | $1.94M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.3% | 17,546 | 15,538 | $1.83M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 4.5% | 15,958 | 11,418 | $1.57M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.8% | 11,124 | 9,572 | $983K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.5% | 11,092 | 8,153 | $849K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 2.4% | 6,487 | 4,809 | $836K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.4% | 7,816 | 7,202 | $823K |
| 99442 | 1.8% | 7,971 | 7,733 | $625K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.6% | 16,930 | 15,024 | $548K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.5% | 16,984 | 12,146 | $528K |
274 more codes
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.5% | 27,987 | $512K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.4% | 7,659 | $484K |
| 86480 | 1.4% | 7,952 | $472K | |
| D9999 | Unspecified adjunctive procedure, by report | 1.1% | 2,702 | $391K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 8,921 | $385K |
| 99203 | Doctor's office visit, new patient (routine) | 1.1% | 3,357 | $382K |
| D0999 | Unspecified diagnostic procedure, by report | 1.1% | 2,366 | $378K |
| 80061 | Lipid panel | 1.1% | 30,109 | $365K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.0% | 2,276 | $362K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 10,907 | $330K |
| 99441 | <1% | 5,256 | $320K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 21,715 | $308K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 16,821 | $308K |
| 85027 | <1% | 40,354 | $305K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,496 | $300K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 12,176 | $299K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 3,243 | $294K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,644 | $287K |
| 80053 | Comprehensive metabolic panel | <1% | 24,180 | $285K |
| 90461 | <1% | 5,387 | $261K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 29,133 | $245K |
| 86769 | <1% | 7,911 | $226K | |
| 90651 | <1% | 3,263 | $222K | |
| 83655 | <1% | 12,479 | $213K | |
| 81001 | <1% | 27,075 | $209K | |
| 86703 | <1% | 14,588 | $205K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,386 | $202K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 510 | $192K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 23,956 | $189K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,877 | $189K |
| 90677 | <1% | 1,179 | $180K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 8,312 | $175K |
| 99201 | <1% | 2,612 | $171K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12,781 | $163K |
| 90837 | Psychotherapy session, about an hour | <1% | 1,105 | $157K |
| 90686 | <1% | 14,269 | $155K | |
| 90746 | <1% | 2,542 | $154K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 3,246 | $128K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 1,493 | $128K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 5,704 | $127K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,471 | $125K |
| 86780 | <1% | 10,182 | $124K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,400 | $113K |
| 90697 | <1% | 928 | $111K | |
| 90620 | <1% | 1,464 | $109K | |
| 99205 | Prolong outpt/office vis | <1% | 669 | $102K |
| 80076 | <1% | 11,976 | $97K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 3,999 | $95K |
| 99383 | <1% | 800 | $94K | |
| D1110 | Prophylaxis - adult | <1% | 4,060 | $91K |
| 96127 | <1% | 15,046 | $85K | |
| 0012A | <1% | 2,121 | $84K | |
| 86803 | <1% | 6,888 | $81K | |
| 99384 | <1% | 616 | $78K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,810 | $78K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 932 | $77K |
| D0120 | Dental checkup, returning patient | <1% | 5,167 | $77K |
| 99443 | <1% | 1,621 | $75K | |
| 0011A | <1% | 2,176 | $73K | |
| 90715 | <1% | 3,068 | $73K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 584 | $73K |
| 99385 | <1% | 517 | $70K | |
| 99381 | <1% | 736 | $70K | |
| 96112 | <1% | 621 | $64K | |
| 0064A | <1% | 1,417 | $59K | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 3,219 | $57K |
| 82948 | <1% | 4,423 | $57K | |
| 92015 | Determination of refractive state | <1% | 2,425 | $54K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 883 | $54K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 415 | $53K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,625 | $53K |
| D1120 | Dental cleaning, child | <1% | 2,816 | $52K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,604 | $52K |
| 91322 | <1% | 591 | $51K | |
| 86706 | <1% | 5,267 | $51K | |
| 87800 | <1% | 1,375 | $49K | |
| 90732 | <1% | 472 | $46K | |
| 99382 | <1% | 400 | $44K | |
| 87340 | <1% | 4,454 | $43K | |
| 00120 | <1% | 1,591 | $40K | |
| 90674 | <1% | 1,366 | $39K | |
| 86762 | <1% | 2,916 | $39K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,241 | $39K |
| 96130 | <1% | 485 | $37K | |
| 99051 | <1% | 1,693 | $36K | |
| G0470 | Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | <1% | 2,639 | $36K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,778 | $34K |
| 90480 | <1% | 799 | $34K | |
| 90670 | <1% | 2,143 | $34K | |
| 86765 | <1% | 2,754 | $33K | |
| 81002 | <1% | 3,518 | $33K | |
| 82043 | <1% | 6,435 | $32K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,470 | $31K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,131 | $31K |
| 3074F | <1% | 14,088 | $31K | |
| 90716 | <1% | 1,060 | $30K | |
| 99386 | <1% | 177 | $28K | |
| 86787 | <1% | 2,661 | $28K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 1,181 | $27K |
| 86735 | <1% | 2,581 | $27K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 561 | $27K |
| 88142 | <1% | 1,134 | $26K | |
| 90750 | <1% | 146 | $26K | |
| 84153 | <1% | 1,673 | $25K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 533 | $25K |
| 0134A | <1% | 606 | $25K | |
| 92250 | <1% | 595 | $24K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 136 | $23K |
| 81025 | <1% | 3,979 | $23K | |
| 87081 | <1% | 2,418 | $23K | |
| 99429 | <1% | 412 | $23K | |
| 90707 | <1% | 905 | $22K | |
| 99401 | <1% | 847 | $22K | |
| 92002 | <1% | 255 | $22K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 3,319 | $20K |
| 90734 | <1% | 1,727 | $20K | |
| 82607 | <1% | 1,413 | $19K | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 1,257 | $18K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 647 | $18K |
| 90714 | <1% | 854 | $18K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 456 | $18K |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | <1% | 26 | $18K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,551 | $17K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,325 | $17K |
| 84439 | <1% | 2,072 | $16K | |
| 87486 | <1% | 518 | $16K | |
| 0071A | <1% | 355 | $16K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 2,861 | $16K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 356 | $15K |
| 87581 | <1% | 518 | $15K | |
| 90633 | <1% | 2,134 | $14K | |
| 0072A | <1% | 309 | $14K | |
| 95834 | <1% | 310 | $14K | |
| 92523 | <1% | 61 | $14K | |
| 90656 | <1% | 1,411 | $14K | |
| 90662 | <1% | 470 | $13K | |
| 82728 | <1% | 1,083 | $13K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 89 | $13K |
| 0124A | <1% | 271 | $12K | |
| D0274 | Bitewings - four radiographic images | <1% | 1,358 | $12K |
| 96161 | <1% | 1,295 | $12K | |
| 82274 | <1% | 1,044 | $11K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,437 | $10K |
| 83020 | <1% | 820 | $10K | |
| 81003 | <1% | 4,496 | $9K | |
| 92551 | <1% | 405 | $9K | |
| 84702 | <1% | 631 | $9K | |
| 83550 | <1% | 1,238 | $9K | |
| 83540 | <1% | 1,554 | $8K | |
| G0467 | Community health center visit, returning patient | <1% | 2,803 | $7K |
| 76830 | Ultrasound, transvaginal | <1% | 68 | $7K |
| 97802 | <1% | 624 | $6K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 1,749 | $6K |
| 87536 | <1% | 68 | $6K | |
| D1206 | Topical application of fluoride varnish | <1% | 588 | $6K |
| 86696 | <1% | 354 | $6K | |
| 98960 | <1% | 256 | $6K | |
| 86708 | <1% | 506 | $6K | |
| 82465 | <1% | 644 | $5K | |
| 72100 | <1% | 123 | $5K | |
| 96136 | <1% | 72 | $5K | |
| 86850 | <1% | 315 | $5K | |
| 96131 | <1% | 90 | $5K | |
| 86704 | <1% | 470 | $5K | |
| 82951 | <1% | 517 | $5K | |
| 0154A | <1% | 104 | $5K | |
| 85660 | <1% | 981 | $4K | |
| 90710 | <1% | 748 | $4K | |
| D1351 | Sealant - per tooth | <1% | 333 | $4K |
| 99173 | <1% | 331 | $4K | |
| 90681 | <1% | 887 | $4K | |
| 93975 | <1% | 24 | $4K | |
| 86901 | <1% | 574 | $4K | |
| D1330 | <1% | 3,143 | $4K | |
| 86695 | <1% | 329 | $4K | |
| 86900 | <1% | 577 | $4K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 129 | $4K |
| 96137 | <1% | 86 | $4K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,717 | $4K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 25 | $3K |
| 86580 | <1% | 384 | $3K | |
| 90653 | <1% | 100 | $3K | |
| 90698 | <1% | 578 | $3K | |
| D0272 | Bitewings - two radiographic images | <1% | 464 | $3K |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 65 | $3K |
| T2022 | Case management, per month | <1% | 78 | $3K |
| 90744 | <1% | 545 | $3K | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 26 | $3K |
| 96160 | <1% | 186 | $3K | |
| 84403 | <1% | 98 | $3K | |
| 90696 | <1% | 523 | $2K | |
| 84146 | <1% | 138 | $2K | |
| 90694 | <1% | 73 | $2K | |
| 82947 | <1% | 611 | $2K | |
| 0081A | <1% | 48 | $2K | |
| 97168 | <1% | 27 | $2K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 13 | $2K |
| 86140 | <1% | 442 | $2K | |
| 0004A | <1% | 42 | $2K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 172 | $2K |
| 92227 | <1% | 95 | $2K | |
| 84460 | <1% | 358 | $2K | |
| 83525 | <1% | 163 | $2K | |
| 90723 | <1% | 497 | $2K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 12 | $2K |
| 84703 | <1% | 340 | $2K | |
| 0074A | <1% | 33 | $1K | |
| 86038 | <1% | 162 | $1K | |
| 86592 | <1% | 413 | $1K | |
| 81015 | <1% | 567 | $1K | |
| 73630 | <1% | 43 | $1K | |
| 80069 | <1% | 153 | $1K | |
| 0082A | <1% | 29 | $1K | |
| 86593 | <1% | 296 | $1K | |
| 90474 | <1% | 84 | $1K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 12 | $1K |
| 84402 | <1% | 41 | $990.82 | |
| 96113 | <1% | 28 | $970.30 | |
| 86430 | <1% | 187 | $961.24 | |
| 90647 | <1% | 340 | $949.64 | |
| 84550 | <1% | 240 | $914.80 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 13 | $857.78 |
| 83001 | <1% | 52 | $852.80 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 279 | $831.57 |
| 91319 | <1% | 31 | $830.68 | |
| 97763 | <1% | 13 | $676.50 | |
| 86360 | <1% | 13 | $653.20 | |
| 87522 | Neg quan hep c or qual rna | <1% | 15 | $637.21 |
| 91320 | <1% | 15 | $633.42 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 151 | $617.31 |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 222 | $573.86 |
| 0001A | <1% | 12 | $568.40 | |
| 82105 | <1% | 53 | $557.94 | |
| 86359 | <1% | 13 | $541.16 | |
| 87338 | <1% | 39 | $484.41 | |
| Q3014 | Telehealth originating site facility fee | <1% | 41 | $476.56 |
| 97116 | <1% | 105 | $471.38 | |
| 85610 | <1% | 131 | $457.92 | |
| 83002 | <1% | 26 | $414.83 | |
| 96380 | <1% | 15 | $388.50 | |
| 85651 | <1% | 119 | $386.83 | |
| 90672 | <1% | 67 | $362.47 | |
| 90713 | <1% | 46 | $326.80 | |
| 82570 | <1% | 80 | $319.07 | |
| 87186 | <1% | 40 | $311.91 | |
| 90756 | <1% | 14 | $299.21 | |
| 85730 | <1% | 37 | $220.85 | |
| 90648 | <1% | 73 | $214.22 | |
| 84156 | <1% | 54 | $151.86 | |
| D0270 | <1% | 30 | $110.78 | |
| 82248 | <1% | 27 | $107.46 | |
| 90660 | <1% | 14 | $104.68 | |
| D0601 | <1% | 208 | $88.32 | |
| 84100 | <1% | 25 | $86.17 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 286 | $65.82 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 12 | $27.16 |
| 90685 | <1% | 93 | $17.85 | |
| 3079F | 0% | 4,807 | $0.00 | |
| 3075F | 0% | 3,318 | $0.00 | |
| 3044F | 0% | 114 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 407 | $0.00 |
| 3080F | 0% | 942 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 108 | $0.00 |
| 1220F | 0% | 547 | $0.00 | |
| D0603 | 0% | 100 | $0.00 | |
| 3077F | 0% | 1,753 | $0.00 | |
| 3078F | 0% | 12,157 | $0.00 | |
| 1159F | 0% | 1,189 | $0.00 | |
| 99499 | 0% | 668 | $0.00 | |
| D0191 | 0% | 361 | $0.00 | |
| 1160F | 0% | 734 | $0.00 | |
| D0190 | 0% | 331 | $0.00 | |
| 99080 | 0% | 61 | $0.00 | |
| G0466 | Community health center visit, new patient | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKARLIN, MARJI (ASSISTANT VICE PRESIDENT)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.